Fischer Medical Ventures Limited has informed the exchange on the receipt of Circular from National Stock Exchange of India (NSE) relating to Listing of Equity shares in the Main Board of NSE
FISCHER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fischer Medical Ventures Limited (formerly Fischer Chemic Limited) will have its 6,48,51,547 equity shares of face value Rs. 10 each listed on the Main Board of NSE from July 10, 2025, under the trading symbol 'FISCHER' and ISIN INE771F01025. The stock is already listed on BSE (Scrip Code: 524743), so this is effectively a dual-listing move that makes the shares tradable on India's largest stock exchange as well. The company is based in Visakhapatnam with a corporate office in Chennai and operates in the medical devices/healthcare space. Lot size is 1 share and trading will happen in the Normal Market segment in compulsory demat form for all investors. The NSE circular also reveals several pre-listing lock-in tranches: about 4 crore shares are locked until August 30, 2025, around 1.03 crore shares until November 15, 2025, and smaller parcels unlocking through September–November 2025.
Dual listing on NSE should improve visibility, liquidity, and potentially valuation discovery for Fischer Medical shareholders. However, investors should note the staggered lock-in expiries from August to November 2025 — once these locked shares become freely tradable, they could create supply-side pressure on the stock price.